Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by elgin1on Jun 24, 2020 7:22pm

99 Views

Post# 31188308

RE:elgin1 - ViaCyte & SVA

That atricle is not written by Viacycte themselves. They do not say they have measured c peptide . There is nothing official from the company only that their chairman has been fired from vertex for personal issues..... why would they mention that?

Reeks of desperation if you ask me.

Elgin

Bullboard Posts

A potential breakthrough in spinal cord and optic nerve injury treatment